课题基金 / 基金详情

IMSD at the University of Rochester

IMSD at the University of Rochester
罗彻斯特大学 IMSD
批准号:
10552964
负责人:
CRAIG N MORRELL
金额:
$16.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2028-01-31
关键词:

项目摘要

项目成果

CRAIG N MORRELL的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要:罗切斯特中心的主要目标:教育和促进聋人/聋人 听力研究生(THREADgS)是严格培养聋人和重听人(D/HH)的博士前 并支持他们在生物医学研究企业内进入独立的学术生涯。 这是一个关键的未得到满足的国家需求:D/HH群体在生物医学科学中的代表性严重不足 教师队伍。即便如此,美国任何一所研究密集型大学都没有T32项目 专注于培养D/HH研究生。罗切斯特大学(UR)和罗切斯特社区 作为一个整体,有资源和基础设施来支持D/HH学习者在所有其他职业阶段。作为UR 扩大对D/HH学习者的支持,THREADgS还将刺激基础设施的进一步发展,以 支持美国手语(ASL)口译员的科学术语培训 机制。它将改善D/HH科学家的环境,通过“指导导师”积极维护 面向D/HH学员的包容性沟通策略。此外,通过自由传播我们的方法和成果, 这一建议的成功实施将改善对各地D/HH STEM研究生的培训。 我们的目标是:1.)美国国立卫生研究院B类D/HH研究生人数在五年内翻一番 在生物医学研究中代表性严重不足的人口统计学--残疾人。2.) 完成NIGMS资助的生物医学研究D/HH培训管道,目前支持 本科生、硕士生和博士生,但不包括研究生。这是唯一的职业发展途径 对于任何研究密集型机构的D/HH个人。3.)显著改进聋人感知辅导 通过正规培训的机构支持。4.)促进留住、社会凝聚力和认同感 在D/HH研究生学者中增加生物医学研究人员,以提高毕业率和减少培训时间。5.) 通过为已建立的技术词典做出贡献,改进对所有D/HH生物医学研究人员的科学培训 美国手语(ASL)中的符号,并作为同行自由传播我们的方法和结果- 评论文章。我们每年将招聘3名新的博士/HH学者,最长任期为3年 T32资助,以保持计划内9名D/HH学者的稳定状态。随着学员离开T32基金 并完成研究生学习,他们将建立一个更大的D/HH学者社区。总体而言,这款独特的T32 该计划将使我们的学者掌握成功职业生涯所需的知识和研究技能 进步。最终目标是我们的学者将在高等教育中实现全日制学术任命 教育和/或研究机构减少为国家生物医学服务的D/HH教师的匮乏 研究需求。
英文摘要
Project Summary: The primary objective of The Hub at Rochester: Educating and Advancing Deaf/hard of hearing graduate Students, (THREADgS) is to rigorously train deaf and hard of hearing (D/HH) pre-doctoral Scholars and support their advance into independent academic careers within biomedical research enterprise. This is a vital unmet national need: the D/HH community is greatly underrepresented in the biomedical science academic workforce. Even so, there is no T32 program at any United States research-intensive university that focuses on training D/HH graduate students. The University of Rochester (UR) and the Rochester community as a whole have the resources and infrastructure to support D/HH learners at all other career stages. As the UR expands support for D/HH learners, THREADgS will also stimulate the further development of infrastructure to support American Sign Language (ASL) interpreter training in scientific terminology through a centralized mechanism. It will improve the environment for D/HH scientists, by “mentoring the mentors” to actively maintain inclusive communication strategies for D/HH trainees. Also, by freely disseminating our approach and outcomes, a successful implementation of this proposal will improve training for D/HH STEM graduate students everywhere. Our goals are: 1.) Double the number of D/HH graduate Scholars at URSMD in five years, an NIH Category B demographic – individuals with disabilities – that are critically underrepresented in biomedical research. 2.) Complete our NIGMS-funded pipeline for D/HH training in biomedical research, which currently supports undergraduates, masters’ students, and Ph.D. fellows, but not graduate Scholars. This is the only career pipeline for D/HH individuals at any research-intensive institution. 3.) Dramatically improve Deaf-aware mentoring through institutional support of formal training. 4.) Promote retention, social cohesion, and identification as biomedical researchers among D/HH graduate Scholars to improve graduate rates and reduce training time. 5.) Improve scientific training for all D/HH biomedical researchers by contributing to established lexicons of technical signs in American Sign Language (ASL) and by freely disseminating both our approach and outcomes as peer- reviewed articles. We will recruit 3 new D/HH scholars per year, with a maximum of a three-year appointment in T32 funding, to maintain a steady state of 9 D/HH Scholars within the program. As trainees leave T32 funding and complete their graduate studies, they will build a larger D/HH scholar community. Overall, this unique T32 program will equip our Scholars with the knowledge and research skills necessary for successful career advancement. The ultimate goal is that our Scholars will achieve full-time academic appointments in higher education and/or research institutions to reduce the dearth of D/HH faculty serving the nation's biomedical research needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue Dependent Megakaryocyte Functions
  • 批准号:
    10337469
  • 项目类别:
  • 资助金额:
    $50.91万
  • 财政年份:
    2022
  • 负责人:
    CRAIG N MORRELL
  • 依托单位:
Tissue Dependent Megakaryocyte Functions
  • 批准号:
    10569096
  • 项目类别:
  • 资助金额:
    $50.91万
  • 财政年份:
    2022
  • 负责人:
    CRAIG N MORRELL
  • 依托单位:
Platelet-Regulated Immune Responses in Neonates Following Transfusion
  • 批准号:
    10217253
  • 项目类别:
  • 资助金额:
    $19.25万
  • 财政年份:
    2020
  • 负责人:
    CRAIG N MORRELL
  • 依托单位:
Platelet-Regulated Immune Responses in Neonates Following Transfusion
  • 批准号:
    10039184
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2020
  • 负责人:
    CRAIG N MORRELL
  • 依托单位:
海外基金